Tatouage et réaction sarcoïdosique()

Por Dréno, B.
Publicado no Bull Acad Natl Med (2020)

Acne relapses: impact on quality of life and productivity

Por Dreno, B., Bordet, C., Seite, S., Taieb, C.
Publicado no J Eur Acad Dermatol Venereol (2019)

Comparison of three culture media for the establishment of melanoma cell lines

Por Pandolfino, M. C., Saïagh, S., Knol, A. C., Dréno, B.
Publicado em 2010

Chilblains and COVID19 infection: Causality or coincidence? How to proceed?

Por Pistorius, M.A., Blaise, S., Le Hello, C., Barbarot, S., Dréno, B.
Publicado no J Med Vasc (2020)

The influence of exposome on acne

Por Dréno, B., Bettoli, V., Araviiskaia, E., Sanchez Viera, M., Bouloc, A.
Publicado no J Eur Acad Dermatol Venereol (2018)

A Full GMP Process to Select and Amplify Epitope-Specific T Lymphocytes for Adoptive Immunotherapy of Metastatic Melanoma

Por Labarriere, N., Fortun, A., Bellec, A., Khammari, A., Dreno, B., Saïagh, S., Lang, F.
Publicado em 2013

A skincare combined with combination of adapalene and benzoyl peroxide provides a significant adjunctive efficacy and local tolerance benefit in adult women with mild acne

Por Bouloc, A., Roo, E., Imko‐Walczuk, B., Moga, A., Chadoutaud, B., Dréno, B.
Publicado no J Eur Acad Dermatol Venereol (2017)

Daily baseline skin care in the prevention, treatment, and supportive care of skin toxicity in oncology patients: recommendations from a multinational expert panel

Por Bensadoun RJ, Humbert P, Krutman J, Luger T, Triller R, Rougier A, Seite S, Dreno B
Publicado em 2013-12-01

Algorithm for dermocosmetic use in the management of cutaneous side-effects associated with targeted therapy in oncology

Por Dreno, B, Bensadoun, RJ, Humbert, P, Krutmann, J, Luger, T, Triller, R, Rougier, A, Seité, S
Publicado em 2013

PD-1 expression conditions T cell avidity within an antigen-specific repertoire

Por Simon, Sylvain, Vignard, Virginie, Florenceau, Laetitia, Dreno, B., Khammari, A., Lang, F., Labarriere, N.
Publicado no Oncoimmunology (2015)

The impact of airborne pollution on skin

Por Araviiskaia, E., Berardesca, E., Bieber, T., Gontijo, G., Sanchez Viera, M., Marrot, L., Chuberre, B., Dreno, B.
Publicado no J Eur Acad Dermatol Venereol (2019)

Control of growth and differentiation of normal human epithelial cells through the manipulation of reactive nitrogen species.

Por Vallette, G, Tenaud, I, Branka, J E, Jarry, A, Sainte-Marie, I, Dreno, B, Laboisse, C L
Publicado em 1998

Microbiome in healthy skin, update for dermatologists

Por Dréno, B., Araviiskaia, E., Berardesca, E., Gontijo, G., Sanchez Viera, M., Xiang, L.F., Martin, R., Bieber, T.
Publicado no J Eur Acad Dermatol Venereol (2016)

Interest of corrective makeup in the management of patients in dermatology

Por Seité, S, Deshayes, P, Dréno, B, Misery, L, Reygagne, P, Saiag, P, Stengel, F, Roguedas-Contios, AM, Rougier, A
Publicado em 2012

Specificity of T cells invading the skin during acute graft-vs.-host disease after semiallogeneic bone marrow transplantation.

Por Gaschet, J, Mahé, B, Milpied, N, Devilder, M C, Dréno, B, Bignon, J D, Davodeau, F, Hallet, M M, Bonneville, M, Vié, H
Publicado em 1993

Immunotherapy of distant metastatic disease

Por Schadendorf, D., Algarra, S. M., Bastholt, L., Cinat, G., Dreno, B., Eggermont, A. M. M., Espinosa, E., Guo, J., Hauschild, A., Petrella, T., Schachter, J., Hersey, P.
Publicado em 2009

Photoprotection according to skin phototype and dermatoses: practical recommendations from an expert panel

Por Passeron, T., Lim, H.W., Goh, C.‐L., Kang, H.Y., Ly, F., Morita, A., Ocampo Candiani, J., Puig, S., Schalka, S., Wei, L., Dréno, B., Krutmann, J.
Publicado no J Eur Acad Dermatol Venereol (2021)

First-in-human phase I study of the DNA-repair inhibitor DT01 in combination with radiotherapy in patients with skin metastases from melanoma

Por Le Tourneau, C, Dreno, B, Kirova, Y, Grob, J J, Jouary, T, Dutriaux, C, Thomas, L, Lebbé, C, Mortier, L, Saiag, P, Avril, M F, Maubec, E, Joly, P, Bey, P, Cosset, J M, Sun, J S, Asselain, B, Devun, F, Marty, M E, Dutreix, M
Publicado no Br J Cancer (2016)

Prospective assessment of a gene signature potentially predictive of clinical benefit in metastatic melanoma patients following MAGE-A3 immunotherapeutic (PREDICT)

Por Saiag, P., Gutzmer, R., Ascierto, P. A., Maio, M., Grob, J.-J., Murawa, P., Dreno, B., Ross, M., Weber, J., Hauschild, A., Rutkowski, P., Testori, A., Levchenko, E., Enk, A., Misery, L., Vanden Abeele, C., Vojtek, I., Peeters, O., Brichard, V. G., Therasse, P.
Publicado no Ann Oncol (2016)

Safety and immunogenicity of the PRAME cancer immunotherapeutic in metastatic melanoma: results of a phase I dose escalation study

Por Gutzmer, R, Rivoltini, L, Levchenko, E, Testori, A, Utikal, J, Ascierto, P A, Demidov, L, Grob, J J, Ridolfi, R, Schadendorf, D, Queirolo, P, Santoro, A, Loquai, C, Dreno, B, Hauschild, A, Schultz, E, Lesimple, T P, Vanhoutte, N, Salaun, B, Gillet, M, Jarnjak, S, De Sousa Alves, P M, Louahed, J, Brichard, V G, Lehmann, F F
Publicado no ESMO Open (2016)